[Netilmicin in single daily doses for the bacterial bronchopulmonary complications in patients with advanced bronchogenic carcinoma].
In 40 patients with bacterial bronchopulmonary complications during polychemotherapy for advanced bronchogenic carcinoma, once-daily netilmicin (4.5 mg/kg every 24 h) brought about complete resolution of the infective process in 90% of the cases and eradication of the responsible pathogen in 82%. This result must be considered good in view of the patients' precarious condition due to their advanced neoplastic disease.
Zubiani
M
M
Aquilini
M
M
Gagliardi
A
A
Lucifora
V
V
Mariani
M A
MA
Notaro
F M
FM
Ranieri
G
G
Signora
M
M
Franchino
L
L
Salvati
F
F
D000328:Adult; D000368:Aged; D002283:Carcinoma, Bronchogenic / Q000150:complications* / Q000382:microbiology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009428:Netilmicin / Q000008:administration & dosage / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology
D009428:Netilmicin
La netilmicina in monodose giornaliera nelle complicanze batteriche broncopolmonari in pazienti con carcinoma broncogeno avanzato.